Actelion Stock

Stocks

31/07/17	Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake	RE
19/07/17	Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast	RE
19/07/17	Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast	RE
10/06/17	Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16	RE
10/06/17	Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16	RE
09/06/17	Actelion : Johnson & Johnson expects to complete of Actelion offer on June 16	RE
22/05/17	Akzo Nobel : Cross-border M&A between U.S. and European firms at 10 year high	RE
18/05/17	Actelion : Johnson & Johnson offers EU concessions over Actelion deal	RE
20/04/17	Actelion : Johnson & Johnson target Actelion could exit Swiss benchmark SMI index this month	RE
18/04/17	Actelion : Johnson & Johnson first quarter revenue misses estimates; new forecast includes Actelion	RE
05/04/17	Actelion : shareholders back R&D spinoff, keep J&J deal on track	RE
31/03/17	Actelion : J&J declares Actelion tender offer a success, sees closing in second quarter	RE
23/02/17	Genmab A/S : and J&J's cancer drug set for blockbuster sales this year	RE

06/04/20	Actelion : Pharmaceuticals US, Inc, - Results from Expert Delphi Consensus Survey on Treatment of Pulmonary Arterial Hypertension with Oral Prostacyclin Pathway Agents	AQ
31/10/17	Actelion : Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017	GL
30/06/17	Actelion : Befreiung von Publizitätspflichten zur Aufrechterhaltung der Kotierung	GL
16/06/17	Actelion : Johnson & Johnson Completes Acquisition of Actelion	GL
16/06/17	Actelion : Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange	PU

29/01/18	Après Bioverativ, Sanofi s'empare de la biotech belge Ablynx pour 3,9 mrd EUR
29/01/18	Après Bioverativ, Sanofi rachète la biotech belge Ablynx pour 3,9 mrd EUR
22/01/18	Avec Bioverativ, Sanofi devient un leader mondial dans l'hémophilie
31/10/17	Actelion : Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017
30/10/17	Actelion: la décotation est agendée au 7 novembre

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACTELION	-.--%	+0.99%	-	-	0
WUXI APPTEC CO., LTD.	-2.11%	-1.68%	+43.40%	+95.27%	66.93B
ARGENX SE	-0.23%	-4.45%	+32.50%	+75.75%	61.97B
INSMED INCORPORATED	+1.67%	+2.47%	-11.32%	+380.54%	28.26B
WUXI BIOLOGICS (CAYMAN) INC.	-1.05%	-4.43%	+28.84%	+10.59%	24.59B
BIONTECH SE	+0.34%	-6.78%	-0.01%	-16.35%	24.3B
GENMAB A/S	+0.43%	-3.37%	+16.22%	-17.99%	19.41B
PHARMAESSENTIA CORPORATION	-3.03%	-2.29%	+181.72%	+335.27%	16.77B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.94%	-4.94%	-8.15%	+483.69%	14.18B
SUMMIT THERAPEUTICS INC.	+3.24%	-0.31%	-7.34%	+880.45%	14B
Average	-0.27%	-2.95%	+30.65%	+247.47%	30.05B
Weighted average by Cap.	-0.56%	-2.83%	+31.25%	+170.65%